<!DOCTYPE html><html><head><meta charSet="utf-8" class="next-head"/><title class="next-head">ALiEM Cards</title><meta name="viewport" content="initial-scale=1.0, width=device-width" class="next-head"/><meta charset="utf-8" class="next-head"/><meta http-equiv="x-ua-compatible" content="ie=edge" class="next-head"/><link rel="apple-touch-icon" sizes="180x180" href="/static/Favicons/apple-touch-icon.png" class="next-head"/><link rel="icon" type="image/png" href="/static/Favicons/favicon-32x32.png" sizes="32x32" class="next-head"/><link rel="icon" type="image/png" href="/static/Favicons/favicon-16x16.png" sizes="16x16" class="next-head"/><link rel="mask-icon" href="/static/Favicons/safari-pinned-tab.svg" color="#00b092" class="next-head"/><link rel="shortcut icon" href="/static/Favicons/favicon.ico" class="next-head"/><link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Open+Sans" class="next-head"/><link rel="preload" href="/_next/static/1~ee3OFOv6kXxZUoU_eCb/pages/card.js" as="script"/><link rel="preload" href="/_next/static/1~ee3OFOv6kXxZUoU_eCb/pages/_app.js" as="script"/><link rel="preload" href="/_next/static/1~ee3OFOv6kXxZUoU_eCb/pages/_error.js" as="script"/><link rel="preload" href="/_next/static/runtime/webpack-89179faa512dd01fbb62.js" as="script"/><link rel="preload" href="/_next/static/chunks/commons.ce4c8f8c27f9b1d9e256.js" as="script"/><link rel="preload" href="/_next/static/chunks/styles.9b76ae77785496d5351a.js" as="script"/><link rel="preload" href="/_next/static/runtime/main-cfdfd101abde4b1d3f2a.js" as="script"/><link rel="stylesheet" href="/_next/static/css/commons.b3e9c004.chunk.css"/><link rel="stylesheet" href="/_next/static/css/styles.0fc85b66.chunk.css"/></head><body><div id="__next"><div data-reactroot=""><div><div class="header" role="banner"><div class="header__logo"><a href="/"><img src="/static/logo.svg"/></a></div><div class="header__nav-button"><button class="hamburger hamburger__squeeze"><span class="hamburger__box"><span class="hamburger__inner"></span></span></button></div><nav class="header__nav header__nav--closed" role="navigation"><ul><li><a href="/cards/">Cards</a></li><li><a href="/categories/">Categories</a></li><li><a href="/about/">About</a></li></ul></nav></div><div class="search"><div class="search__input" role="search"><input type="text" placeholder="Search" aria-label="Search for cards" value=""/></div></div></div><main class="content container" role="main"><article role="article"><h1>Bell&#x27;s Palsy Treatment</h1><div class="card"><div class="card__meta"><div><strong>Author: </strong>Michelle Lin, MD</div><div><strong>Updated:</strong> <!-- -->2/21/2013</div></div><div class="card__content"><h1 id="bell-s-palsy-treatment">Bell&#39;s Palsy Treatment</h1>
<h2 id="treatment">Treatment</h2>
<ul>
<li>Corticosteroids, if onset within 72 hours</li>
<li>1 in 11 were helped (to complete recovery) - <a href="http://www.thennt.com/nnt/steroids-for-bells-palsy/">NNT.com</a></li>
<li><strong><span class="drug">Prednisone</span>:</strong> 60 mg daily x 1 week. May consider taper for days #8-10</li>
<li><span class="drug">Artificial tears</span> in daytime and lubricating eye ointment at night to prevent corneal drying and exposure</li>
<li>Tape eyelid shut while asleep.</li>
</ul>
<p>Controversial benefit of antivirals (at most risk difference of 7%):</p>
<ul>
<li>American Academy of Neurology (2012), JAMA (2009), and UpToDate suggest giving for severe cases such as for Grade IV and higher</li>
<li>Cochrane review (2009): No antivirals indicated. </li>
<li><strong><span class="drug">Valacylovir</strong></span> 1000 mg TID or <strong><span class="drug">Acyclovir</strong></span> 400 mg 5x daily x 1 week</li>
<li>Also prescribe <span class="drug">corticosteroids</span>, if antivirals given.</li>
</ul>
<h2 id="house-brackmann-grading-for-severity-of-facial-nerve-weakness">House-Brackmann grading for severity of facial nerve weakness</h2>
<table>
<thead>
<tr>
<th align="center">Grade</th>
<th align="center">Dysfunction</th>
<th>Gross weakness</th>
<th>At rest</th>
<th>Motion</th>
</tr>
</thead>
<tbody><tr>
<td align="center">I</td>
<td align="center">None</td>
<td>No weakness</td>
<td>No weakness</td>
<td>Normal function all groups</td>
</tr>
<tr>
<td align="center">II</td>
<td align="center">Mild</td>
<td>Slight weakness noticeable on close inspection. May have very slight synkinesis</td>
<td>Normal symmetry and tone</td>
<td><strong>Forehead</strong>: Moderate-to-good function  <strong>Mouth</strong>: Slight asymmetry</td>
</tr>
<tr>
<td align="center">III</td>
<td align="center">Moderate</td>
<td>Obvious but not disfiguring difference; noticeable but not severe synkinesis, contracture, and/or hemifacial spasm</td>
<td>Normal symmetry and tone</td>
<td><strong>Forehead</strong>: Slight-to-moderate movement  <strong>Mouth</strong>: Slightly weak with maximum effort</td>
</tr>
<tr>
<td align="center">IV</td>
<td align="center">Moderately severe</td>
<td>Obvious weakness and/or disfiguring asymmetry</td>
<td>Normal symmetry and tone</td>
<td><strong>Forehead</strong>: None  <strong>Mouth</strong>: Asymmetric with maximum effort</td>
</tr>
<tr>
<td align="center">V</td>
<td align="center">Severe</td>
<td>Only barely perceptible motion</td>
<td>Asymmetry</td>
<td><strong>Forehead</strong>: None      <strong>Mouth</strong>: Slight movement</td>
</tr>
<tr>
<td align="center">VI</td>
<td align="center">Total paralysis</td>
<td>No movement</td>
<td>Asymmetry</td>
<td>None for all groups</td>
</tr>
</tbody></table>
<h2 id="references">References</h2>
<ul>
<li>Gronseth GS, Paduga R; American Academy of Neurology. Evidence-based guideline update: steroids and antivirals for Bell palsy: report of the Guideline Development Subcommittee of the American Academy of Neurology. Neurology. 2012 Nov 27;79(22):2209-13. doi: 10.1212/WNL.0b013e318275978c. Epub 2012 Nov 7. [<a href="https://www.ncbi.nlm.nih.gov/pubmed/23136264">PubMed</a>]</li>
<li>de Almeida JR, Al Khabori M, Guyatt GH, Witterick IJ, Lin VY, Nedzelski JM, Chen JM. Combined corticosteroid and antiviral treatment for Bell palsy: a systematic review and meta-analysis. JAMA. 2009 Sep 2;302(9):985-93. doi: 10.1001/jama.2009.1243. [<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=19724046">PubMed</a>]</li>
<li>Lockhart P, Daly F, Pitkethly M, Comerford N, Sullivan F. Antiviral treatment for Bell&#39;s palsy (idiopathic facial paralysis). Cochrane Database Syst Rev. 2009 Oct 7;(4):CD001869. doi: 10.1002/14651858.CD001869.pub4. [<a href="https://www.ncbi.nlm.nih.gov/pubmed/19821283">PubMed</a>]</li>
</ul>
</div></div></article></main><div class="footer" role="contentinfo"><div class="container"><div class="row footer__cc"><div class="footer__cc-image"><a rel="license" href="http://creativecommons.org/licenses/by-nc-nd/3.0/"><img alt="creative-commons" src="/static/by-nc-nd.svg"/></a></div><div class="footer__cc-text">This work is licensed under a<!-- --> <a rel="license" href="http://creativecommons.org/licenses/by-nc-nd/3.0/">Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported License</a>.</div></div><div class="row footer__links"><div><a href="/contact/">Contact</a></div><div><a href="/contact/">Get Involved</a></div><div><a href="/about/">About</a></div></div><div class="row row--centered"><div class="container footer__disclaimer">ALiEM Cards content is intended for use by healthcare professionals. Users of this site should exercise their own clinical judgment as to the reliability and accuracy of its information. Non-healthcare-professionals who use this site do so at their own risk. Content on this site should not be construed as medical advice. Users should always confer with medical profoessionals regarding decisions about medications, evaluations and other medical treatments.</div></div></div></div></div></div><script>__NEXT_DATA__ = {"props":{"pageProps":{"card":{"slug":"bells-palsy-treatment","title":"Bell's Palsy Treatment","authors":["Michelle Lin, MD"],"categories":[{"slug":"neurology","name":"Neurology"}],"created":"2013/02/21","updated":"2017/02/13","body":"\n# Bell's Palsy Treatment\n\n## Treatment\n\n- Corticosteroids, if onset within 72 hours\n- 1 in 11 were helped (to complete recovery) - [NNT.com](http://www.thennt.com/nnt/steroids-for-bells-palsy/)\n- **\u003cspan class=\"drug\"\u003ePrednisone\u003c/span\u003e:** 60 mg daily x 1 week. May consider taper for days #8-10\n- \u003cspan class=\"drug\"\u003eArtificial tears\u003c/span\u003e in daytime and lubricating eye ointment at night to prevent corneal drying and exposure\n- Tape eyelid shut while asleep.\n\nControversial benefit of antivirals (at most risk difference of 7%):\n\n- American Academy of Neurology (2012), JAMA (2009), and UpToDate suggest giving for severe cases such as for Grade IV and higher\n- Cochrane review (2009): No antivirals indicated. \n- **\u003cspan class=\"drug\"\u003eValacylovir**\u003c/span\u003e 1000 mg TID or **\u003cspan class=\"drug\"\u003eAcyclovir**\u003c/span\u003e 400 mg 5x daily x 1 week\n- Also prescribe \u003cspan class=\"drug\"\u003ecorticosteroids\u003c/span\u003e, if antivirals given.\n\n## House-Brackmann grading for severity of facial nerve weakness\n\n|  Grade |    Dysfunction    | Gross weakness                                                                                                     | At rest                  |  Motion                                                                                 |\n| :----: | :---------------: | ------------------------------------------------------------------------------------------------------------------ | ------------------------ | --------------------------------------------------------------------------------------- |\n|    I   |        None       | No weakness                                                                                                        | No weakness              | Normal function all groups                                                              |\n|   II   |        Mild       | Slight weakness noticeable on close inspection. May have very slight synkinesis                                    | Normal symmetry and tone | **Forehead**: Moderate-to-good function  **Mouth**: Slight asymmetry                    |\n|   III  |      Moderate     | Obvious but not disfiguring difference; noticeable but not severe synkinesis, contracture, and/or hemifacial spasm | Normal symmetry and tone | **Forehead**: Slight-to-moderate movement  **Mouth**: Slightly weak with maximum effort |\n|   IV   | Moderately severe | Obvious weakness and/or disfiguring asymmetry                                                                      | Normal symmetry and tone | **Forehead**: None  **Mouth**: Asymmetric with maximum effort                           |\n|    V   |       Severe      | Only barely perceptible motion                                                                                     | Asymmetry                | **Forehead**: None      **Mouth**: Slight movement                                      |\n|   VI   |  Total paralysis  | No movement                                                                                                        | Asymmetry                | None for all groups                                                                     |\n\n## References\n\n- Gronseth GS, Paduga R; American Academy of Neurology. Evidence-based guideline update: steroids and antivirals for Bell palsy: report of the Guideline Development Subcommittee of the American Academy of Neurology. Neurology. 2012 Nov 27;79(22):2209-13. doi: 10.1212/WNL.0b013e318275978c. Epub 2012 Nov 7. [[PubMed](https://www.ncbi.nlm.nih.gov/pubmed/23136264)]\n- de Almeida JR, Al Khabori M, Guyatt GH, Witterick IJ, Lin VY, Nedzelski JM, Chen JM. Combined corticosteroid and antiviral treatment for Bell palsy: a systematic review and meta-analysis. JAMA. 2009 Sep 2;302(9):985-93. doi: 10.1001/jama.2009.1243. [[PubMed](https://www.ncbi.nlm.nih.gov/pubmed/?term=19724046)]\n- Lockhart P, Daly F, Pitkethly M, Comerford N, Sullivan F. Antiviral treatment for Bell's palsy (idiopathic facial paralysis). Cochrane Database Syst Rev. 2009 Oct 7;(4):CD001869. doi: 10.1002/14651858.CD001869.pub4. [[PubMed](https://www.ncbi.nlm.nih.gov/pubmed/19821283)]\n"}}},"page":"/card","pathname":"/card","query":{"slug":"bells-palsy-treatment"},"buildId":"1~ee3OFOv6kXxZUoU_eCb","nextExport":true};__NEXT_LOADED_PAGES__=[];__NEXT_REGISTER_PAGE=function(r,f){__NEXT_LOADED_PAGES__.push([r, f])}</script><script async="" id="__NEXT_PAGE__/card" src="/_next/static/1~ee3OFOv6kXxZUoU_eCb/pages/card.js"></script><script async="" id="__NEXT_PAGE__/_app" src="/_next/static/1~ee3OFOv6kXxZUoU_eCb/pages/_app.js"></script><script async="" id="__NEXT_PAGE__/_error" src="/_next/static/1~ee3OFOv6kXxZUoU_eCb/pages/_error.js"></script><script src="/_next/static/runtime/webpack-89179faa512dd01fbb62.js" async=""></script><script src="/_next/static/chunks/commons.ce4c8f8c27f9b1d9e256.js" async=""></script><script src="/_next/static/chunks/styles.9b76ae77785496d5351a.js" async=""></script><script src="/_next/static/runtime/main-cfdfd101abde4b1d3f2a.js" async=""></script></body></html>